LailaBabarMD

PubMed

• Schnitzler’s Syndrome: A Diagnostic Consideration in Evaluating the Constellation of Monoclonal Gammopathy and Chronic Urticaria
  Jyothika Mamadgi, Laila Babar, Rama Bhagavatula, Santhosh Sadashiv, Kossivi Dantey, Mariya Apostolova> ;Journal of Hematology. 2021 Jun 16
• 18 citations
  Intratumoral immunotherapy with STING agonist, ADU-S100, induces CD8+ T-cell mediated anti-tumor immunity in an esophageal adenocarcinoma model.
  Ali H. Zaidi, Ronan J. Kelly, Anastasia Gorbunova, Ashten N. Omstead, Madison Salvitti, Ping Zheng, Juliann E. Kosovec, Soyoung Lee, Shahin Ayazi, Laila Babar, Gene Gr...> ;Oncotarget. 2021 Feb 16
• A Retrospective Analysis of Factors Affecting Palliative Care Consults in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
  Robin Raquel Rodriguez, Laila Babar, Herman Lo, Obaid Ashraf, Dulabh Monga, Gene Grant Finley, Lisa Doverspike, Amber Blackledge, Ashish Sethi, Moses S. Raj> ;Cureus. 2021 Jan 9
• 4 citations
  Retrospective review of total neoadjuvant therapy
  Laila Babar, Veli Bakalov, Stephen Abel, Obaid Ashraf, Gene Grant Finley, Moses S. Raj, Kristina Lundeen, Dulabh Monga, Alexander V. Kirichenko, Rodney E. Wegner> ;World Journal of Gastrointestinal Oncology. 2019 Oct 15
• 9 citations
  Prognostic immune markers for recurrence and survival in locally advanced esophageal adenocarcinoma.
  Laila Babar, Juliann E. Kosovec, Vida Jahangiri, Nobel Chowdhury, Ping Zheng, Ashten N. Omstead, Madison Salvitti, Matthew A. Smith, Ajay Goel, Ronan J. Kelly, Blair A...> ;Oncotarget. 2019 Jul 16
• Join now to see all

Lectures

• Potency of CD8+ T-cell mediated antitumor immunity from intratumoral immunotherapy with STING agonist, ADU-S100, in an esophageal adenocarcinoma model. 
  ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/23/2020
• A retrospective analysis of factors affecting palliative care consult in patients undergoing cytoreductive surgery and HIPEC. 
  ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/23/2020
• Evaluation of readmission rates for gastrointestinal bleeds in high risk oncologic patients. 
  ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019